Renovacor Announces the Appointment of Fred Driscoll as Chief Financial Officer
Mr. Driscoll has over 25 years of biotech executive experience and most recently served as the CFO of Flexion Therapeutics through its sale to Pacira BioSciences for up to $1 billion ... | March 28, 2022
Source: marketscreener.com